Investor Relations.
Vivos Inc. (Trading symbol OTCQB:RDGL) is committed to providing shareholders with complete, up-to-the-minute information about the company. Within this section of our website, you'll find Press Releases, Financial Information, Board of Directors, Committee Composition, Governance Documents, and other corporate information.
Thank you for your past and continued support investing in Vivos Inc., and for supporting our mission of developing technologies that will improve human life.
RadioGel™ is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.
